Jun 13, 2022 / 10:20PM GMT
Chris Shibutani - Goldman Sachs Group, Inc., Research Division - Research Analyst
Okay. I think we're right on time. Welcome, everybody, to the Goldman Sachs Healthcare Conference. It's fantastic to see everybody in person here. We are so pleased to kick off our event today with participation of Merck's CEO, Rob Davis; President of Merck Research Labs, Dean Li. Gentlemen, thank you both for making me (inaudible) here and coming. I know that many of the investors you've been meeting with are also deeply appreciative especially for the time of a CEO to be present here for this event.
Rob, you've been at Merck for a while in the C-suite. The past year, however, has been your opportunity to have the purview of the CEO role, overall, it's a very different place. A lot has happened. Talk to us maybe some opening comments about how you feel Merck's outlook and what you feel are some of your priorities now as we sit here, so that next year when we sit here, once again, I can see how you're progressing on them, but as a CEO now for a year...
Robert M. Davis - Merck & Co.,
Merck & Co Inc at Goldman Sachs Global Healthcare Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers